About Genesis Capital
Genesis Capital is a private equity firm founded in 2015. It is primarily based in Beijing, China. In the last 12 months, it has participated in 2 funding rounds.
Overall Genesis Capital portfolio has seen 3 unicorns, 4 IPOs and 3 acquisitions including key companies like 4Paradigm, Beisen and Meicai. A lot of funds co-invest with Genesis Capital, with names like Vision Plus Capital sharing a substantial percentage of its portfolio.
Genesis Capital has a team of 16 people, including 7 partners.
Key Metrics
Genesis Capital's Portfolio
They have invested in a total of 41 companies. Their most recent investment was in Motorevo (Series A round) on Apr 21, 2026. Here is the most recent investment by Genesis Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Apr 21, 2026 | Series A | 1287 | ||
Sep 21, 2025 | Series B | 4864 | ||
May 28, 2025 | Series B | 6222 | ||
Jul 14, 2024 | Series A | 4390 |
Here is the portfolio snapshot of Genesis Capital:
Investments by Year
The maximum number of investments were made in 2017
Team profile of Genesis Capital
Genesis Capital has a team of 16 members including 7 Partners and 4 Principals located in China and United States. Genesis Capital's team does not sit on the board of any company as of now.Here is a list of top team members in Genesis Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Shanghai | - | ||
Partner | Beijing | - | ||
Partner | - | - | ||
Partner | Shanghai | - | - | |
Partner | Haidian | - | - | |
Partner | Hong Kong | - | ||
Partner | Beijing | - | - | |
Principal | China | - | ||
Principal | Washington, DC | - | ||
Principal | Chaoyang | - | - | |
Principal | China | - | - |
Co-investors of Genesis Capital
Over the past 11 years, 58 investors have co-invested in Genesis Capital's portfolio companies.
- Top Co-investors of Genesis Capital: 58 investors entered a company along with Genesis Capital. These include investors like Vision Plus Capital (3 companies).
Genesis Capital News
•
•
•
•
•
•
•
•
•
Chinese drug R&D platform Yaoyanshe pockets $86m in Series C+, DDeal Street Asia•Aug 10, 2020•Yaoyanshe, Yuan Jing Capital, Matrix Partners China, Bell Capital and 3 others
•
